704 related articles for article (PubMed ID: 10572324)
1. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
2. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Bennie EH; Mullin JM; Martindale JJ
J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
[TBL] [Abstract][Full Text] [Related]
3. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
5. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
[TBL] [Abstract][Full Text] [Related]
6. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
[TBL] [Abstract][Full Text] [Related]
7. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Fava M; Hoog SL; Judge RA; Kopp JB; Nilsson ME; Gonzales JS
J Clin Psychopharmacol; 2002 Apr; 22(2):137-47. PubMed ID: 11910258
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
[TBL] [Abstract][Full Text] [Related]
12. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
Feiger AD; Flament MF; Boyer P; Gillespie JA
Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
[TBL] [Abstract][Full Text] [Related]
13. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
[TBL] [Abstract][Full Text] [Related]
14. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
Newhouse PA; Krishnan KR; Doraiswamy PM; Richter EM; Batzar ED; Clary CM
J Clin Psychiatry; 2000 Aug; 61(8):559-68. PubMed ID: 10982198
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
Boyer P; Danion JM; Bisserbe JC; Hotton JM; Troy S
Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):157-69. PubMed ID: 10184835
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Mehtonen OP; Søgaard J; Roponen P; Behnke K
J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
[TBL] [Abstract][Full Text] [Related]
19. A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.
Søgaard J; Lane R; Latimer P; Behnke K; Christiansen PE; Nielsen B; Ravindran AV; Reesal RT; Goodwin DP
J Psychopharmacol; 1999 Dec; 13(4):406-14. PubMed ID: 10667618
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Demyttenaere K; Corruble E; Hale A; Quera-Salva MA; Picarel-Blanchot F; Kasper S
CNS Spectr; 2013 Jun; 18(3):163-70. PubMed ID: 23472671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
